These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26503996)

  • 21. Surgery for gastrointestinal stromal tumour in the post-imatinib era.
    Neuhaus SJ; Clark MA; Hayes AJ; Thomas JM; Judson I
    ANZ J Surg; 2005 Mar; 75(3):165-72. PubMed ID: 15777399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
    Rutkowski P; Nowecki Z; Nyckowski P; Dziewirski W; Grzesiakowska U; Nasierowska-Guttmejer A; Krawczyk M; Ruka W
    J Surg Oncol; 2006 Mar; 93(4):304-11. PubMed ID: 16496358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively].
    Okuda H; Tanaka H; Ueno M; Shitani M; Nasuno M; Suzuki C; Nishimura S; Kimura H; Yonezawa K; Abe T; Yoshida Y; Kawabata M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1941-4. PubMed ID: 16282731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical management of tyrosine kinase inhibitor-associated side effects in GIST.
    Joensuu H; Trent JC; Reichardt P
    Cancer Treat Rev; 2011 Feb; 37(1):75-88. PubMed ID: 20570050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).
    Fiore M; Palassini E; Fumagalli E; Pilotti S; Tamborini E; Stacchiotti S; Pennacchioli E; Casali PG; Gronchi A
    Eur J Surg Oncol; 2009 Jul; 35(7):739-45. PubMed ID: 19110398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    McAuliffe JC; Lazar AJ; Yang D; Steinert DM; Qiao W; Thall PF; Raymond AK; Benjamin RS; Trent JC
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6727-34. PubMed ID: 18006774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gastrointestinal stromal tumors: diagnosis and treatment. Our experience].
    Zanghì G; Di Stefano G; Di Dio D; D'Agati V; Benfatto G; Basile F
    G Chir; 2011; 32(1-2):29-33. PubMed ID: 21352704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of adjuvant imatinib in patients with gastrointestinal stromal tumor: results of a population-based, matched-cohort study.
    Hatoum HT; Lin SJ; Sasane M; Trent JC
    Curr Med Res Opin; 2012 May; 28(5):805-14. PubMed ID: 22506625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment.
    Yeh CN; Chen TW; Tseng JH; Liu YY; Wang SY; Tsai CY; Chiang KC; Hwang TL; Jan YY; Chen MF
    J Surg Oncol; 2010 Nov; 102(6):599-603. PubMed ID: 20976730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible modulation of concurrent Parkinson's disease in the management of metastatic GIST: a review of two cases.
    Watson-Fargie T; Grosset DG; White J; Cowie F
    J R Coll Physicians Edinb; 2018 Sep; 48(3):242-245. PubMed ID: 30191913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced gastrointestinal stromal tumors: 10-years experience from a tertiary care centre.
    Iqbal N; Sharma A; Shukla N; Mohanti BK; Deo SV; Sahni P; Pal S; Pathy S; Raina V; Kumar L
    Trop Gastroenterol; 2015; 36(3):168-73. PubMed ID: 27522735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of imatinib plasma concentration monitoring in the whole process management of gastrointestinal stromal tumor patients].
    Yang LX; Wang M; Xu RH; Tu L; Zhuang C; Zhao WY; Ma XL; Li M; Zhang J; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):841-847. PubMed ID: 31550823
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report.
    Hughes B; Yip D; Goldstein D; Waring P; Beshay V; Chong G
    BMC Cancer; 2004 Oct; 4():74. PubMed ID: 15473910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCBE1 promotes GIST development through enhancing angiogenesis and mediating resistance to imatinib.
    Tian GA; Zhu CC; Zhang XX; Zhu L; Yang XM; Jiang SH; Li RK; Tu L; Wang Y; Zhuang C; He P; Li Q; Cao XY; Cao H; Zhang ZG
    Sci Rep; 2016 Aug; 6():31071. PubMed ID: 27506146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
    Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
    Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
    Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
    Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
    Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
    Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal stromal tumors (GIST) related emergencies.
    Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
    Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.